Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone.

Autor:	Derosa, G.1 giuseppe.derosa@unipv.it, Fogari, E.1, D'Angelo, A.1, Cicero, A. F. G.2, Salvadeo, S. A. T.1, Ragonesi, P. D.3, Ferrari, I.1, Gravina, A.1, Fassi, R.1, Fogari, R.1
Zdroj:	Journal of Clinical Pharmacy & Therapeutics. Jun2007, Vol. 32 Issue 3, p261-268. 8p. 1 Chart, 2 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu